Key Highlights
● AIZ closed at $266.23 on 9 October 2026, and the $324.29 consensus target implies upside of about 21.8%.
● The consensus draws on eight analysts, with targets from $300 to $355, while the second data set shows a $330 mean from seven analysts.
● Market data lists a Buy consensus, with six Buy and two Strong Buy ratings and no Hold or Sell.
● Morgan Stanley cut its target to $300 from $320 on 6 October, the most recent named change after a run of August increases.
Assurant, Inc. (NYSE:AIZ), a constituent of the S&P 500, closed at $266.23 on Friday 9 October 2026. Analysts covering the shares currently publish price targets well above that level.
What Is the Latest Analyst Price Target?
According to market data, the consensus 12-month price target for Assurant is $324.29, based on eight analysts with ratings in the past year. Measured against the $266.23 close, that implies upside of about 21.8%. The highest target is $355 and the lowest is $300.
The second data set, which draws on third-party data, shows a slightly higher mean of $330, a median of $327, a high of $355 and a low of $320 from seven analysts.
The mean sits close to the average of the recent named broker targets listed below, so it does not appear to be inflated by stale figures.
What Are Wall Street Analysts Saying?
Market data lists a Buy consensus: six Buy and two Strong Buy ratings, with no Hold or Sell ratings. The second data set shows a similar picture, with four Strong Buy and three Buy ratings and no Holds or Sells.
Named broker actions over the past few months were mostly constructive, although the most recent change was a reduction. On 6 October 2026, Morgan Stanley cut its target from $320 to $300 while keeping an Overweight rating. In August, Truist raised its target from $310 to $355 with a Buy rating, UBS lifted its target from $274 to $331 with a Buy rating, Piper Sandler raised from $290 to $329 with an Overweight rating, and Keefe, Bruyette & Woods raised from $310 to $325 with an Outperform rating, and BMO Capital Markets raised from $274 to $320 with an Outperform rating.
Market data also records changes from quantitative rating services, which differ from traditional broker research.
What Could Help the Stock Reach the Price Target?
The gap between the share price and the targets leaves room for the stock to re-rate if the company delivers on analysts' expectations.
Steady execution in the company's insurance and services businesses, disciplined underwriting and continued capital returns are the sort of factors that analysts commonly cite for specialty insurers.
What Could Prevent the Stock Reaching the Target?
The latest move among the named brokers, Morgan Stanley's target cut, is a reminder that estimates can be revised downwards.
Insurers can be exposed to catastrophe losses, claims inflation, interest-rate movements and changes in consumer demand. Any of these could pressure earnings and lead analysts to lower forecasts.
Assurant's Unanimous Buy Ratings Meet a Lone October Target Cut
Assurant closed at $266.23 on 9 October 2026, with the $324.29 consensus target about 21.8% higher and the second data set's $330 mean pointing to a similar gap. Ratings are uniformly positive, with no Hold or Sell in either data set, and August brought sizeable increases from Truist to $355, UBS to $331 and Piper Sandler to $329. The latest named move is Morgan Stanley's cut to $300 from $320, a reminder that estimates can be revised down even among a Buy-rated panel.






Please wait processing your request...